NASDAQ:ICLR - Icon Stock Price, Price Target & More

Icon trades on the NASDAQ under the ticker symbol "ICLR."

Icon Plc (NASDAQ:ICLR) announced its quarterly earnings results on Thursday, May, 3rd. The medical research company reported $1.42 earnings per share for the quarter, beating analysts' consensus estimates of $1.41 by $0.01. The medical research company earned $620.13 million during the quarter, compared to analysts' expectations of $562.61 million. Icon had a return on equity of 26.56% and a net margin of 14.80%. The business's revenue for the quarter was up 43.6% on a year-over-year basis. During the same quarter last year, the business posted $1.29 earnings per share. View Icon's Earnings History.

Icon is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Icon.

Icon issued an update on its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share (EPS) guidance of $5.91-6.11 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.99. The company issued revenue guidance of $2.52-2.64 billion, compared to the consensus revenue estimate of $2.25 billion.

10 brokerages have issued 1 year price objectives for Icon's shares. Their forecasts range from $114.00 to $152.00. On average, they anticipate Icon's stock price to reach $129.40 in the next year. View Analyst Ratings for Icon.

Some companies that are related to Icon include IQVIA (IQV), Incyte (INCY), EXACT Sciences (EXAS), PRA Health Sciences (PRAH), Exelixis (EXEL), Charles River Laboratories Intl. (CRL), Syneos Health (SYNH), BTG (BTGGF), Intrexon (XON), Medpace (MEDP), National Research (NRCIB), Sorrento Therapeutics (SRNE), National Research (NRCIA), Eloxx Pharmaceuticals (ELOX) and Viralytics (VRACY).

News headlines about ICLR stock have been trending somewhat positive this week, according to Accern. The research firm scores the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Icon earned a media sentiment score of 0.19 on Accern's scale. They also gave news stories about the medical research company an impact score of 46.20 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Icon's stock is owned by a variety of of institutional and retail investors. Top institutional investors include WCM Investment Management CA (8.25%), Earnest Partners LLC (4.01%), Wasatch Advisors Inc. (3.07%), Boston Partners (3.01%), Wells Fargo & Company MN (1.93%) and Principal Financial Group Inc. (1.75%). View Institutional Ownership Trends for Icon.

ICLR stock was sold by a variety of institutional investors in the last quarter, including Westfield Capital Management Co. LP, Earnest Partners LLC, Envestnet Asset Management Inc., Wasatch Advisors Inc., Victory Capital Management Inc., Fiera Capital Corp, Wells Fargo & Company MN and Loomis Sayles & Co. L P. View Insider Buying and Selling for Icon.

ICLR stock was bought by a variety of institutional investors in the last quarter, including Boston Partners, WCM Investment Management CA, Principal Financial Group Inc., Principal Financial Group Inc., Lord Abbett & CO. LLC, Massachusetts Financial Services Co. MA, American Century Companies Inc. and Baird Financial Group Inc.. View Insider Buying and Selling for Icon.

Shares of ICLR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ICLR stock can currently be purchased for approximately $134.77.

Icon has a market capitalization of $7.33 billion and generates $1.76 billion in revenue each year. The medical research company earns $281.48 million in net income (profit) each year or $5.39 on an earnings per share basis. Icon employs 13,250 workers across the globe.

Icon's mailing address is SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN, DUBLIN L2, 00000. The medical research company can be reached via phone at 353-1291-2000.